Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Clinical and magnetic resonance imaging features of children, adolescents, and adults with a clinically isolated syndrome.

Milos RI, Szimacsek M, Leutmezer F, Rostasy K, Blaschek A, Karenfort M, Schimmel M, Pritsch M, Storm Van's Gravesande K, Weber M, Schmoeger M, Seidl R, Prayer D, Kornek B.

Eur J Paediatr Neurol. 2018 Aug 28. pii: S1090-3798(17)31679-3. doi: 10.1016/j.ejpn.2018.08.003. [Epub ahead of print]

PMID:
30195407
2.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.

Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators.

Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23.

PMID:
29576505
3.

Management of multiple sclerosis patients in central European countries: current needs and potential solutions.

Berger T, Adamczyk-Sowa M, Csépány T, Fazekas F, Hojs Fabjan T, Horáková D, Illes Z, Klimová E, Leutmezer F, Rejdak K, Rozsa C, Šega Jazbec S, Szilasiová J, Turčáni P, Vachová M, Vécsei L, Havrdová E.

Ther Adv Neurol Disord. 2018 Feb 22;11:1756286418759189. doi: 10.1177/1756286418759189. eCollection 2018. Review.

4.

Epidemiology of Multiple Sclerosis in Austria.

Salhofer-Polanyi S, Cetin H, Leutmezer F, Baumgartner A, Blechinger S, Dal-Bianco A, Altmann P, Bajer-Kornek B, Rommer P, Guger M, Leitner-Bohn D, Reichardt B, Alasti F, Temsch W, Stamm T.

Neuroepidemiology. 2017;49(1-2):40-44. doi: 10.1159/000479696. Epub 2017 Aug 19.

PMID:
28848208
5.

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients-A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness.

Ehler J, Blechinger S, Rommer PS, Koball S, Mitzner S, Hartung HP, Leutmezer F, Sauer M, Zettl UK.

Int J Mol Sci. 2017 Aug 11;18(8). pii: E1749. doi: 10.3390/ijms18081749.

6.

Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.

Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Höftberger R, Berger T, Auff E, Leutmezer F, Trattnig S, Lassmann H, Bagnato F, Hametner S.

Acta Neuropathol. 2017 Jan;133(1):25-42. doi: 10.1007/s00401-016-1636-z. Epub 2016 Oct 27.

7.

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD.

Zeka B, Hastermann M, Kaufmann N, Schanda K, Pende M, Misu T, Rommer P, Fujihara K, Nakashima I, Dahle C, Leutmezer F, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol Commun. 2016 Aug 8;4(1):82. doi: 10.1186/s40478-016-0355-y.

8.

Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.

Tuller F, Holzer H, Schanda K, Aboulenein-Djamshidian F, Höftberger R, Khalil M, Seifert-Held T, Leutmezer F, Berger T, Reindl M.

J Neuroinflammation. 2016 Jul 1;13(1):176. doi: 10.1186/s12974-016-0642-3.

9.

Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.

Zeka B, Hastermann M, Hochmeister S, Kögl N, Kaufmann N, Schanda K, Mader S, Misu T, Rommer P, Fujihara K, Illes Z, Leutmezer F, Sato DK, Nakashima I, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol. 2015 Dec;130(6):783-98. doi: 10.1007/s00401-015-1501-5. Epub 2015 Nov 3.

10.

Veins in plaques of multiple sclerosis patients - a longitudinal magnetic resonance imaging study at 7 Tesla.

Dal-Bianco A, Hametner S, Grabner G, Schernthaner M, Kronnerwetter C, Reitner A, Vass C, Kircher K, Auff E, Leutmezer F, Vass K, Trattnig S.

Eur Radiol. 2015 Oct;25(10):2913-20. doi: 10.1007/s00330-015-3719-y. Epub 2015 Apr 23.

PMID:
25903703
11.

Elevated levels of carbonyl proteins in cerebrospinal fluid of patients with neurodegenerative diseases.

Rommer PS, Greilberger J, Salhofer-Polanyi S, Auff E, Leutmezer F, Herwig R.

Tohoku J Exp Med. 2014 Dec;234(4):313-7. doi: 10.1620/tjem.234.313.

12.

Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia.

Altmann P, Mildner M, Haider T, Traxler D, Beer L, Ristl R, Golabi B, Gabriel C, Leutmezer F, Ankersmit HJ.

Version 2. F1000Res. 2014 Jun 19 [revised 2014 Jan 1];3:131. doi: 10.12688/f1000research.4219.2. eCollection 2014.

13.

Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.

Aboul-Enein F, Seifert-Held T, Mader S, Kuenz B, Lutterotti A, Rauschka H, Rommer P, Leutmezer F, Vass K, Flamm-Horak A, Stepansky R, Lang W, Fertl E, Schlager T, Heller T, Eggers C, Safoschnik G, Fuchs S, Kraus J, Assar H, Guggenberger S, Reisz M, Schnabl P, Komposch M, Simschitz P, Skrobal A, Moser A, Jeschow M, Stadlbauer D, Freimüller M, Guger M, Schmidegg S, Franta C, Weiser V, Koppi S, Niederkorn-Duft M, Raber B, Schmeissner I, Jecel J, Tinchon A, Storch MK, Reindl M, Berger T, Kristoferitsch W.

PLoS One. 2013 Nov 5;8(11):e79649. doi: 10.1371/journal.pone.0079649. eCollection 2013.

14.

Benefits of inpatient multidisciplinary rehabilitation in multiple sclerosis.

Salhofer-Polanyi S, Windt J, Sumper H, Grill H, Essmeister M, Diermayr G, Zebenholzer K, Leutmezer F, Zulehner G, Vass K, Asenbaum-Nan S.

NeuroRehabilitation. 2013;33(2):285-92. doi: 10.3233/NRE-130956.

PMID:
23949063
15.

Exploratory investigation of eight circulating plasma markers in brain tumor patients.

Ilhan-Mutlu A, Wagner L, Widhalm G, Wöhrer A, Bartsch S, Czech T, Heinzl H, Leutmezer F, Prayer D, Marosi C, Base W, Preusser M.

Neurosurg Rev. 2013 Jan;36(1):45-55; discussion 55-6. doi: 10.1007/s10143-012-0401-6. Epub 2012 Jul 5.

PMID:
22763625
16.

Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients.

Schmied MC, Zehetmayer S, Reindl M, Ehling R, Bajer-Kornek B, Leutmezer F, Zebenholzer K, Hotzy C, Lichtner P, Meitinger T, Wichmann HE, Illig T, Gieger C, Huber K, Khalil M, Fuchs S, Schmidt H, Auff E, Kristoferitsch W, Fazekas F, Berger T, Vass K, Zimprich A.

Neurogenetics. 2012 May;13(2):181-7. doi: 10.1007/s10048-012-0316-y. Epub 2012 Mar 14.

PMID:
22411505
17.

Brain natriuretic peptide correlates with the extent of atrial fibrillation-associated silent brain lesions.

Gartner W, Zierhut B, Mineva I, Sodeck G, Leutmezer F, Domanovits H, Prayer D, Wolf F, Base W, Weissel M, Wagner L.

Clin Biochem. 2008 Dec;41(18):1434-9. doi: 10.1016/j.clinbiochem.2008.09.096. Epub 2008 Sep 18.

PMID:
18823968
18.

Postictal psychosis in temporal lobe epilepsy.

Leutmezer F, Podreka I, Asenbaum S, Pietrzyk U, Lucht H, Back C, Benda N, Baumgartner C.

Epilepsia. 2003 Apr;44(4):582-90.

19.

Electrocardiographic changes at the onset of epileptic seizures.

Leutmezer F, Schernthaner C, Lurger S, Pötzelberger K, Baumgartner C.

Epilepsia. 2003 Mar;44(3):348-54.

20.

Serum s-100 protein is not a suitable seizure marker in temporal lobe epilepsy.

Leutmezer F, Wagner O, Baumgartner C.

Epilepsia. 2002 Oct;43(10):1172-4.

Supplemental Content

Loading ...
Support Center